We apply HARDEN to two genes involved in neurodegenerative diseases and find that this method exhibits vastly fewer off-target effects than a dCas9-DNMT3a fusion construct and enables generation of stably methylated cell lines that model epigenetic alterations seen in neurodegenerative disease. The gene discussed is DNMT3A; the disease is neurodegenerative disease.